Disclosure Plus

Exchange: "Trading in DASAN DMC Shares Suspended"

KIM YOON-JEONG
2026-08-28 16:42:54
[E-Daily Reporter KIM YOON-JEONG ] The KOSDAQ Market Division of the Korea Exchange announced on the 28th that it will suspend trading of EnGIS Technologies, Inc.(208860)shares starting September 2.
The suspension is due to changes and cancellations in electronic registration resulting from a stock consolidation.
The suspension will remain in effect until the day before the new shares are relisted.

Economy

Corporation

IT·Science

Economy

'Korea Expo' Makes Stops in Paris, Osaka, and Tokyo Before Landing in the U.S.

The "Korea Expo," a comprehensive consumer goods trade show, opened on the 22nd at Magic Box in downtown Los Angeles and will run through the 24th. This marks the first time the Korea Expo—which debut…
2026-10-24 06:54:22
Shifting from Short-Term to Medium- and Long-Term... Appeal of Commercial Paper as a Funding Source Plummets
2026-10-23 17:57:04
Is the End in Sight for Office Workers’ Excel Nightmare?…'This Company' Hits a '330 Billion Jackpot'
2026-10-23 17:52:04

Corporation

SCL Science Takes on Liver and Ovarian Cancer Vaccines… Aims to File IND Application Next Year [Invest Bio]

SCL Science(246960)is accelerating its new drug development efforts, spearheaded by vaccines for liver and ovarian cancer. With the goal of submitting an Investigational New Drug (IND) application nex…
2026-10-24 06:01:03
Jeong Yong-jin Starts by Replacing E-MART Co., Ltd.’s CEO… Appoints Entire Executive Team in Their 40s
2026-10-23 14:55:06
[Personnel] Shinsegae Co.,Ltd
2026-10-23 14:02:06

IT·Science

Rokit Healthcare Plunges 20% Following FDA Warning Letter to U.S. Partner [K-bio Pulse]

Korean small-cap pharma, biotech, and healthcare stocks moved in opposite directions on Oct. 22, as large-cap chipmakers weakened. Rokit Healthcare posted the steepest decline on the KOSDAQ, while in-…
2026-10-24 06:17:02
ROKIT HEALTHCARE Inc. Plummets 20% Amid Fallout from U.S. Partner’s FDA Warning Letter [Bio Spotlight]
2026-10-24 06:16:02
HANALL BIOPHARMA CO.,LTD’s ‘Batoclimab’ Receives First New Drug Approval in China Nine Years After Technology Export
2026-10-23 21:05:02